APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stool Biomarkers Test

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Stool Biomarkers Test Market Analysis and Forecast 2026-2032

5 July 2026173 pages

Choose your research edition.

Industry ResearchStool Biomarkers Test Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Stool Biomarkers Test Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Stool Biomarkers Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stool Biomarkers Test Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Stool Biomarkers Test Market Analysis and Forecast 2026-2032173 pages · $4,950 USD

Market perspective

The global Stool Biomarkers Test market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Stool Biomarkers Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Stool Biomarkers Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Stool Biomarkers Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Stool Biomarkers Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Stool Biomarkers Test include Genova Diagnostics, BioMrieux Inc, Actim, DiaSorin S.p.A., Beckman Coulter Inc., Alere Inc., Bio Rad Laboratories, Cenogenics Corporation and Siemens Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Stool Biomarkers Test, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Stool Biomarkers Test, also provides the revenue of main regions and countries. Of the upcoming market potential for Stool Biomarkers Test, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Stool Biomarkers Test revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Stool Biomarkers Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Stool Biomarkers Test revenue, projected growth trends, production technology, application and end-user industry.

Stool Biomarkers Test Segment by Company

Genova Diagnostics

BioMrieux Inc

Actim

DiaSorin S.p.A.

Beckman Coulter Inc.

Alere Inc.

Bio Rad Laboratories

Cenogenics Corporation

Siemens Healthcare

Quest Diagnostics Incorporated

Abbott Laboratories

Diagnose IBS

Meridian Bioscience Inc

Stool Biomarkers Test Segment by Type

Cologuard

M2 PK Stool Test

Others

Stool Biomarkers Test Segment by Application

Hospitals

Diagnostic Centres and Laboratories

Academic Institutions

Research Centres and Organizations

Stool Biomarkers Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stool Biomarkers Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stool Biomarkers Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stool Biomarkers Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Stool Biomarkers Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Stool Biomarkers Test company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stool Biomarkers Test revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Stool Biomarkers Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cologuard Major Player Table 3. M2 PK Stool Test Major Player Table 4. Others Major Player Table 5. Global Stool Biomarkers Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Player Table 7. Diagnostic Centres and Laboratories Major Player Table 8. Academic Institutions Major Player Table 9. Research Centres and Organizations Major Player Table 10. Stool Biomarkers Test Industry Trends Table 11. Stool Biomarkers Test Industry Drivers Table 12. Stool Biomarkers Test Industry Opportunities and Challenges Table 13. Stool Biomarkers Test Industry Restraints Table 14. Global Stool Biomarkers Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Stool Biomarkers Test Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Stool Biomarkers Test Market Share by Region (2021-2026) Table 17. Global Stool Biomarkers Test Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Stool Biomarkers Test Market Share by Region (2027-2032) Table 19. Global Stool Biomarkers Test Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Stool Biomarkers Test Revenue Market Share by Players (2021-2026) Table 21. Global Stool Biomarkers Test Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Stool Biomarkers Test Key Players Headquarters & Area Served Table 23. Global Stool Biomarkers Test Players, Product Type & Application Table 24. Global Stool Biomarkers Test Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Stool Biomarkers Test by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Stool Biomarkers Test Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Stool Biomarkers Test Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Stool Biomarkers Test Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Stool Biomarkers Test Revenue Market Share by Type (2021-2026) Table 31. Global Stool Biomarkers Test Revenue Market Share by Type (2027-2032) Table 32. Global Stool Biomarkers Test Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Stool Biomarkers Test Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Stool Biomarkers Test Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Stool Biomarkers Test Revenue Market Share by Application (2021-2026) Table 36. Global Stool Biomarkers Test Revenue Market Share by Application (2027-2032) Table 37. Genova Diagnostics Company Information Table 38. Genova Diagnostics Business Overview Table 39. Genova Diagnostics Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Genova Diagnostics Stool Biomarkers Test Product Portfolio Table 41. Genova Diagnostics Recent Development Table 42. BioMrieux Inc Company Information Table 43. BioMrieux Inc Business Overview Table 44. BioMrieux Inc Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. BioMrieux Inc Stool Biomarkers Test Product Portfolio Table 46. BioMrieux Inc Recent Development Table 47. Actim Company Information Table 48. Actim Business Overview Table 49. Actim Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Actim Stool Biomarkers Test Product Portfolio Table 51. Actim Recent Development Table 52. DiaSorin S.p.A. Company Information Table 53. DiaSorin S.p.A. Business Overview Table 54. DiaSorin S.p.A. Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. DiaSorin S.p.A. Stool Biomarkers Test Product Portfolio Table 56. DiaSorin S.p.A. Recent Development Table 57. Beckman Coulter Inc. Company Information Table 58. Beckman Coulter Inc. Business Overview Table 59. Beckman Coulter Inc. Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Beckman Coulter Inc. Stool Biomarkers Test Product Portfolio Table 61. Beckman Coulter Inc. Recent Development Table 62. Alere Inc. Company Information Table 63. Alere Inc. Business Overview Table 64. Alere Inc. Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Alere Inc. Stool Biomarkers Test Product Portfolio Table 66. Alere Inc. Recent Development Table 67. Bio Rad Laboratories Company Information Table 68. Bio Rad Laboratories Business Overview Table 69. Bio Rad Laboratories Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bio Rad Laboratories Stool Biomarkers Test Product Portfolio Table 71. Bio Rad Laboratories Recent Development Table 72. Cenogenics Corporation Company Information Table 73. Cenogenics Corporation Business Overview Table 74. Cenogenics Corporation Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Cenogenics Corporation Stool Biomarkers Test Product Portfolio Table 76. Cenogenics Corporation Recent Development Table 77. Siemens Healthcare Company Information Table 78. Siemens Healthcare Business Overview Table 79. Siemens Healthcare Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Siemens Healthcare Stool Biomarkers Test Product Portfolio Table 81. Siemens Healthcare Recent Development Table 82. Quest Diagnostics Incorporated Company Information Table 83. Quest Diagnostics Incorporated Business Overview Table 84. Quest Diagnostics Incorporated Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Quest Diagnostics Incorporated Stool Biomarkers Test Product Portfolio Table 86. Quest Diagnostics Incorporated Recent Development Table 87. Abbott Laboratories Company Information Table 88. Abbott Laboratories Business Overview Table 89. Abbott Laboratories Stool Biomarkers Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Abbott Laboratories Stool Biomarkers Test Product Portfolio Table 91. Abbott Laboratories Recent Development Table 92. Diagnose IBS Company Information Table 93. Diagnose IBS Business Overview Table 94. Diagnose IBS Stool Biomarkers Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Diagnose IBS Stool Biomarkers Test Product Portfolio Table 96. Diagnose IBS Recent Development Table 97. Meridian Bioscience Inc Company Information Table 98. Meridian Bioscience Inc Business Overview Table 99. Meridian Bioscience Inc Stool Biomarkers Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Meridian Bioscience Inc Stool Biomarkers Test Product Portfolio Table 101. Meridian Bioscience Inc Recent Development Table 102. North America Stool Biomarkers Test Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Stool Biomarkers Test Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Stool Biomarkers Test Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Stool Biomarkers Test Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Stool Biomarkers Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Stool Biomarkers Test Revenue by Country (2021-2026) & (US$ Million) Table 108. North America Stool Biomarkers Test Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe Stool Biomarkers Test Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Stool Biomarkers Test Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Stool Biomarkers Test Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Stool Biomarkers Test Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Stool Biomarkers Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Stool Biomarkers Test Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe Stool Biomarkers Test Revenue by Country (US$ Million) & (2027-2032) Table 116. China Stool Biomarkers Test Revenue by Type (2021-2026) & (US$ Million) Table 117. China Stool Biomarkers Test Revenue by Type (2027-2032) & (US$ Million) Table 118. China Stool Biomarkers Test Revenue by Application (2021-2026) & (US$ Million) Table 119. China Stool Biomarkers Test Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Stool Biomarkers Test Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Stool Biomarkers Test Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Stool Biomarkers Test Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia Stool Biomarkers Test Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia Stool Biomarkers Test Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia Stool Biomarkers Test Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia Stool Biomarkers Test Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA Stool Biomarkers Test Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA Stool Biomarkers Test Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA Stool Biomarkers Test Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA Stool Biomarkers Test Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA Stool Biomarkers Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA Stool Biomarkers Test Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA Stool Biomarkers Test Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Stool Biomarkers Test Image Figure 2. Global Stool Biomarkers Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stool Biomarkers Test Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cologuard Image Figure 5. M2 PK Stool Test Image Figure 6. Others Image Figure 7. Global Stool Biomarkers Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Stool Biomarkers Test Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Diagnostic Centres and Laboratories Image Figure 11. Academic Institutions Image Figure 12. Research Centres and Organizations Image Figure 13. Global Stool Biomarkers Test Market Size (US$ Million) & (2021-2032) Figure 14. Global Stool Biomarkers Test Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Stool Biomarkers Test Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Stool Biomarkers Test Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Stool Biomarkers Test Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Stool Biomarkers Test Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Stool Biomarkers Test Revenue Market Share by Type (2021-2032) Figure 21. Global Stool Biomarkers Test Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Stool Biomarkers Test Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Stool Biomarkers Test Revenue Market Share by Application (2021-2032) Figure 24. North America Stool Biomarkers Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Stool Biomarkers Test Revenue Share by Type (2021-2032) Figure 26. North America Stool Biomarkers Test Revenue Share by Application (2021-2032) Figure 27. North America Stool Biomarkers Test Revenue Share by Country (2021-2032) Figure 28. United States Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Stool Biomarkers Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Stool Biomarkers Test Revenue Share by Type (2021-2032) Figure 33. Europe Stool Biomarkers Test Revenue Share by Application (2021-2032) Figure 34. Europe Stool Biomarkers Test Revenue Share by Country (2021-2032) Figure 35. Germany Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Stool Biomarkers Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Stool Biomarkers Test Revenue Share by Type (2021-2032) Figure 45. China Stool Biomarkers Test Revenue Share by Application (2021-2032) Figure 46. Asia Stool Biomarkers Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Stool Biomarkers Test Revenue Share by Type (2021-2032) Figure 48. Asia Stool Biomarkers Test Revenue Share by Application (2021-2032) Figure 49. Asia Stool Biomarkers Test Revenue Share by Region (2021-2032) Figure 50. Japan Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Stool Biomarkers Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Stool Biomarkers Test Revenue Share by Type (2021-2032) Figure 58. SAMEA Stool Biomarkers Test Revenue Share by Application (2021-2032) Figure 59. SAMEA Stool Biomarkers Test Revenue Share by Country (2021-2032) Figure 60. Brazil Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Stool Biomarkers Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cologuard
  • M2 PK Stool Test
  • Others
Applications
  • Hospitals
  • Diagnostic Centres and Laboratories
  • Academic Institutions
  • Research Centres and Organizations
Companies covered
  • Genova Diagnostics
  • BioMrieux Inc
  • Actim
  • DiaSorin S.p.A.
  • Beckman Coulter Inc.
  • Alere Inc.
  • Bio Rad Laboratories
  • Cenogenics Corporation
  • Siemens Healthcare
  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • Diagnose IBS
  • Meridian Bioscience Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Stool Biomarkers Test Market by Type
  3. 1.2.1 Global Stool Biomarkers Test Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cologuard
  5. 1.2.3 M2 PK Stool Test
  6. 1.2.4 Others
  7. 1.3 Stool Biomarkers Test Market by Application
  8. 1.3.1 Global Stool Biomarkers Test Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Diagnostic Centres and Laboratories
  11. 1.3.4 Academic Institutions
  12. 1.3.5 Research Centres and Organizations
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Stool Biomarkers Test Market Dynamics
  1. 2.1 Stool Biomarkers Test Industry Trends
  2. 2.2 Stool Biomarkers Test Industry Drivers
  3. 2.3 Stool Biomarkers Test Industry Opportunities and Challenges
  4. 2.4 Stool Biomarkers Test Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Stool Biomarkers Test Market Perspective (2021-2032)
  2. 3.2 Global Stool Biomarkers Test Growth Trends by Region
  3. 3.2.1 Global Stool Biomarkers Test Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Stool Biomarkers Test Market Size by Region (2021-2026)
  5. 3.2.3 Global Stool Biomarkers Test Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Stool Biomarkers Test Revenue by Players
  2. 4.1.1 Global Stool Biomarkers Test Revenue by Players (2021-2026)
  3. 4.1.2 Global Stool Biomarkers Test Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Stool Biomarkers Test Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Stool Biomarkers Test Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Stool Biomarkers Test Key Players Headquarters & Area Served
  7. 4.4 Global Stool Biomarkers Test Players, Product Type & Application
  8. 4.5 Global Stool Biomarkers Test Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Stool Biomarkers Test Market CR5 and HHI
  11. 4.6.3 2025 Stool Biomarkers Test Tier 1, Tier 2, and Tier 3
5 Stool Biomarkers Test Market Size by Type
  1. 5.1 Global Stool Biomarkers Test Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Stool Biomarkers Test Revenue by Type (2021-2032)
  3. 5.3 Global Stool Biomarkers Test Revenue Market Share by Type (2021-2032)
6 Stool Biomarkers Test Market Size by Application
  1. 6.1 Global Stool Biomarkers Test Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Stool Biomarkers Test Revenue by Application (2021-2032)
  3. 6.3 Global Stool Biomarkers Test Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Genova Diagnostics
  2. 7.1.1 Genova Diagnostics Company Information
  3. 7.1.2 Genova Diagnostics Business Overview
  4. 7.1.3 Genova Diagnostics Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Genova Diagnostics Stool Biomarkers Test Product Portfolio
  6. 7.1.5 Genova Diagnostics Recent Developments
  7. 7.2 BioMrieux Inc
  8. 7.2.1 BioMrieux Inc Company Information
  9. 7.2.2 BioMrieux Inc Business Overview
  10. 7.2.3 BioMrieux Inc Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BioMrieux Inc Stool Biomarkers Test Product Portfolio
  12. 7.2.5 BioMrieux Inc Recent Developments
  13. 7.3 Actim
  14. 7.3.1 Actim Company Information
  15. 7.3.2 Actim Business Overview
  16. 7.3.3 Actim Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Actim Stool Biomarkers Test Product Portfolio
  18. 7.3.5 Actim Recent Developments
  19. 7.4 DiaSorin S.p.A.
  20. 7.4.1 DiaSorin S.p.A. Company Information
  21. 7.4.2 DiaSorin S.p.A. Business Overview
  22. 7.4.3 DiaSorin S.p.A. Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DiaSorin S.p.A. Stool Biomarkers Test Product Portfolio
  24. 7.4.5 DiaSorin S.p.A. Recent Developments
  25. 7.5 Beckman Coulter Inc.
  26. 7.5.1 Beckman Coulter Inc. Company Information
  27. 7.5.2 Beckman Coulter Inc. Business Overview
  28. 7.5.3 Beckman Coulter Inc. Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Beckman Coulter Inc. Stool Biomarkers Test Product Portfolio
  30. 7.5.5 Beckman Coulter Inc. Recent Developments
  31. 7.6 Alere Inc.
  32. 7.6.1 Alere Inc. Company Information
  33. 7.6.2 Alere Inc. Business Overview
  34. 7.6.3 Alere Inc. Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Alere Inc. Stool Biomarkers Test Product Portfolio
  36. 7.6.5 Alere Inc. Recent Developments
  37. 7.7 Bio Rad Laboratories
  38. 7.7.1 Bio Rad Laboratories Company Information
  39. 7.7.2 Bio Rad Laboratories Business Overview
  40. 7.7.3 Bio Rad Laboratories Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bio Rad Laboratories Stool Biomarkers Test Product Portfolio
  42. 7.7.5 Bio Rad Laboratories Recent Developments
  43. 7.8 Cenogenics Corporation
  44. 7.8.1 Cenogenics Corporation Company Information
  45. 7.8.2 Cenogenics Corporation Business Overview
  46. 7.8.3 Cenogenics Corporation Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cenogenics Corporation Stool Biomarkers Test Product Portfolio
  48. 7.8.5 Cenogenics Corporation Recent Developments
  49. 7.9 Siemens Healthcare
  50. 7.9.1 Siemens Healthcare Company Information
  51. 7.9.2 Siemens Healthcare Business Overview
  52. 7.9.3 Siemens Healthcare Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Siemens Healthcare Stool Biomarkers Test Product Portfolio
  54. 7.9.5 Siemens Healthcare Recent Developments
  55. 7.10 Quest Diagnostics Incorporated
  56. 7.10.1 Quest Diagnostics Incorporated Company Information
  57. 7.10.2 Quest Diagnostics Incorporated Business Overview
  58. 7.10.3 Quest Diagnostics Incorporated Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Quest Diagnostics Incorporated Stool Biomarkers Test Product Portfolio
  60. 7.10.5 Quest Diagnostics Incorporated Recent Developments
  61. 7.11 Abbott Laboratories
  62. 7.11.1 Abbott Laboratories Company Information
  63. 7.11.2 Abbott Laboratories Business Overview
  64. 7.11.3 Abbott Laboratories Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Abbott Laboratories Stool Biomarkers Test Product Portfolio
  66. 7.11.5 Abbott Laboratories Recent Developments
  67. 7.12 Diagnose IBS
  68. 7.12.1 Diagnose IBS Company Information
  69. 7.12.2 Diagnose IBS Business Overview
  70. 7.12.3 Diagnose IBS Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Diagnose IBS Stool Biomarkers Test Product Portfolio
  72. 7.12.5 Diagnose IBS Recent Developments
  73. 7.13 Meridian Bioscience Inc
  74. 7.13.1 Meridian Bioscience Inc Company Information
  75. 7.13.2 Meridian Bioscience Inc Business Overview
  76. 7.13.3 Meridian Bioscience Inc Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Meridian Bioscience Inc Stool Biomarkers Test Product Portfolio
  78. 7.13.5 Meridian Bioscience Inc Recent Developments
8 North America
  1. 8.1 North America Stool Biomarkers Test Revenue (2021-2032)
  2. 8.2 North America Stool Biomarkers Test Revenue by Type (2021-2032)
  3. 8.2.1 North America Stool Biomarkers Test Revenue by Type (2021-2026)
  4. 8.2.2 North America Stool Biomarkers Test Revenue by Type (2027-2032)
  5. 8.3 North America Stool Biomarkers Test Revenue Share by Type (2021-2032)
  6. 8.4 North America Stool Biomarkers Test Revenue by Application (2021-2032)
  7. 8.4.1 North America Stool Biomarkers Test Revenue by Application (2021-2026)
  8. 8.4.2 North America Stool Biomarkers Test Revenue by Application (2027-2032)
  9. 8.5 North America Stool Biomarkers Test Revenue Share by Application (2021-2032)
  10. 8.6 North America Stool Biomarkers Test Revenue by Country
  11. 8.6.1 North America Stool Biomarkers Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Stool Biomarkers Test Revenue by Country (2021-2026)
  13. 8.6.3 North America Stool Biomarkers Test Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Stool Biomarkers Test Revenue (2021-2032)
  2. 9.2 Europe Stool Biomarkers Test Revenue by Type (2021-2032)
  3. 9.2.1 Europe Stool Biomarkers Test Revenue by Type (2021-2026)
  4. 9.2.2 Europe Stool Biomarkers Test Revenue by Type (2027-2032)
  5. 9.3 Europe Stool Biomarkers Test Revenue Share by Type (2021-2032)
  6. 9.4 Europe Stool Biomarkers Test Revenue by Application (2021-2032)
  7. 9.4.1 Europe Stool Biomarkers Test Revenue by Application (2021-2026)
  8. 9.4.2 Europe Stool Biomarkers Test Revenue by Application (2027-2032)
  9. 9.5 Europe Stool Biomarkers Test Revenue Share by Application (2021-2032)
  10. 9.6 Europe Stool Biomarkers Test Revenue by Country
  11. 9.6.1 Europe Stool Biomarkers Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Stool Biomarkers Test Revenue by Country (2021-2026)
  13. 9.6.3 Europe Stool Biomarkers Test Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Stool Biomarkers Test Revenue (2021-2032)
  2. 10.2 China Stool Biomarkers Test Revenue by Type (2021-2032)
  3. 10.2.1 China Stool Biomarkers Test Revenue by Type (2021-2026)
  4. 10.2.2 China Stool Biomarkers Test Revenue by Type (2027-2032)
  5. 10.3 China Stool Biomarkers Test Revenue Share by Type (2021-2032)
  6. 10.4 China Stool Biomarkers Test Revenue by Application (2021-2032)
  7. 10.4.1 China Stool Biomarkers Test Revenue by Application (2021-2026)
  8. 10.4.2 China Stool Biomarkers Test Revenue by Application (2027-2032)
  9. 10.5 China Stool Biomarkers Test Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Stool Biomarkers Test Revenue (2021-2032)
  2. 11.2 Asia Stool Biomarkers Test Revenue by Type (2021-2032)
  3. 11.2.1 Asia Stool Biomarkers Test Revenue by Type (2021-2026)
  4. 11.2.2 Asia Stool Biomarkers Test Revenue by Type (2027-2032)
  5. 11.3 Asia Stool Biomarkers Test Revenue Share by Type (2021-2032)
  6. 11.4 Asia Stool Biomarkers Test Revenue by Application (2021-2032)
  7. 11.4.1 Asia Stool Biomarkers Test Revenue by Application (2021-2026)
  8. 11.4.2 Asia Stool Biomarkers Test Revenue by Application (2027-2032)
  9. 11.5 Asia Stool Biomarkers Test Revenue Share by Application (2021-2032)
  10. 11.6 Asia Stool Biomarkers Test Revenue by Country
  11. 11.6.1 Asia Stool Biomarkers Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Stool Biomarkers Test Revenue by Country (2021-2026)
  13. 11.6.3 Asia Stool Biomarkers Test Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Stool Biomarkers Test Revenue (2021-2032)
  2. 12.2 SAMEA Stool Biomarkers Test Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Stool Biomarkers Test Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Stool Biomarkers Test Revenue by Type (2027-2032)
  5. 12.3 SAMEA Stool Biomarkers Test Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Stool Biomarkers Test Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Stool Biomarkers Test Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Stool Biomarkers Test Revenue by Application (2027-2032)
  9. 12.5 SAMEA Stool Biomarkers Test Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Stool Biomarkers Test Revenue by Country
  11. 12.6.1 SAMEA Stool Biomarkers Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Stool Biomarkers Test Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Stool Biomarkers Test Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst